Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726293 · ClinicalTrials.gov registry record · NA
Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04726293 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 60 participants.
The verdict
NCT04726293, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary objective of this project is to provide new knowledge through a comprehensive set of analyses that investigate the complex interplay between regular mango intake, gut microbial structure/ function, mechanisms of inflammation and insulin sensitivity in over weight (OW)/obese (OB) human subjects with chronic low-grade inflammation.
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Mango
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2025-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04726293
The ClinicalTrials.gov registry entry for NCT04726293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT04726293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04726293 about?
NCT04726293 is a clinical study titled "Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption". The primary objective of this project is to provide new knowledge through a comprehensive set of analyses that investigate the complex interplay between regular mango intake, gut microbial structure/ function, mechanisms of inflammation and insulin sensitivity in over weight (OW)/obese (OB) human su...
What is the current status of trial NCT04726293?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-02-22. Estimated completion is 2025-04-28.
What interventions are being tested in trial NCT04726293?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Mango (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04726293?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.